Wizcure Pharmaa Recalls Vista Tears Eye Drops Nationwide Over Sterility Concerns

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Wizcure Pharmaa Private Limited is recalling all lots of Vista Tears Eye Drops due to a lack of sterility assurance and manufacturing practice violations.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.

What Happened

Wizcure Pharmaa Private Limited has initiated a voluntary recall of Vista Tears Eye Drops. The recall was issued due to a lack of assurance of sterility, as the products were not manufactured in conformance with current good manufacturing practices (cGMP). The recall is currently classified as a Class II event by the FDA.

Which Products Are Affected

The recall involves Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, used for dry eye relief.

  • Product Name: Vista Tears Lubricant Eye Drops
  • Size: 10 ml (1/3 fl. oz.) sterile bottles
  • NDC Number: 77790-001-10
  • Affected Lots: All lots
  • Quantity: 5,760 cartons
  • Distribution: Distributed nationwide across the United States
  • Manufacturer: Omni Lens Pvt. Ltd. (India) for hi-health (Scottsdale, AZ)

What You Should Do

Consumers should immediately stop using the affected Vista Tears Eye Drops. The recall was initiated via letter to distributors and retailers. Consumers who possess these products should contact their point of purchase or the distributor, hi-health, for further instructions regarding the return or disposal of the product.

Why This Matters

Products intended for use in the eyes must be sterile; a lack of sterility assurance poses a risk of eye infections or other health complications for users. This recall ensures that potentially contaminated products are removed from the market to protect consumer safety.

Source

Information provided by the FDA. Recall Number: D-0346-2026.

Original source: FDA Official Notice ↗

All FDA Recalls →

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Wizcure Pharmaa Private Limited is recalling all lots of Vista Tears Eye Drops due to a lack of sterility assurance and manufacturing practice violations.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.